HOME Top Market Reports Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021

By: marketsandmarkets.com
Publishing Date: November 2016
Report Code: MD 4774

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period. Factors such as growing awareness about various health-related disorders among women, rising incidence of various chronic and lifestyle disorders in women, and high prevalence of infectious diseases such as HIV and hepatitis in women across the globe are driving the growth of the market. Moreover, the increasing adoption of point-of-care diagnostic testing and the increasing number of diagnostic and imaging centers are also expected to play a major role in market growth. However, shortage of skilled laboratory technicians and high costs of diagnostics devices, tests, and procedures are hindering the growth of women health diagnostics market.

In this report, the global women health diagnostics market is segmented on the basis of application and end user. On the basis of application, the market is segmented into nine segments namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound. The osteoporosis segment is further divided into bone densitometry and in vitro blood tests. The ovarian cancer segment is divided into tumor marker tests, diagnostic imaging tests and others. The cervical cancer segment is sub segmented into PAP smear testing and HPV testing. The breast cancer testing segment is further divided into mammography, tumor marker tests, blood cell count & blood chemistries, biopsies and other diagnostic imaging tests. Pregnancy and fertility testing market is sub segmented into lab-based testing, pregnancy self-test and ovulation prediction kits, ovulation prediction kits, fertility monitors and thermometers. The prenatal genetic screening & carrier testing segment is further divided into cystic fibrosis, Down syndrome and Edward syndrome, TORCH infections and others (fragile x-syndrome & tay-sachs diseases). Further on, the infectious disease testing market segment is sub segmented into methicillin-resistant staphylococcus aurea (MRSA), urinary tract infections (vaginal pH & vaginitis), hepatitis, tuberculosis, and others infectious disease testing. The sexually transmitted disease testing segment comprises Chlamydia Trachomatis and Neisseria Gonorrohoeae testing, HIV testing and other STD testing.. The ultrasound segment covers breast imaging and ob/gyn imaging. On the basis of end user, the women’s health diagnostics market is segmented into hospitals & clinics, home care, and diagnostic & imaging centers.

Geographically, the global women’s health diagnostics market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded the largest share of the global women health diagnostics market. The major share of this region can be attributed to increasing prevalence of cancer among women in this region, increasing incidence of lifestyle related health disorders, growing focus of manufacturers of women’s health diagnostic products on expanding their presence in this region, and increasing demand for fertility testing monitors.

The prominent players in this market are Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V. (Netherlands).

Target Audience:

  • Hospitals and Clinics
  • Medical Research and Development (R&D) Companies
  • Medical Device Companies
  • Women Health Diagnostics Solutions’ Vendors
  • Medical Device Manufacturers
  • Imaging and Diagnostic Centers
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report:

The research report categorizes the women’s health diagnostics market into the following segments and subsegments:

Global women’s health diagnostics market, by application

  • Breast Cancer Testing
    • Mammography Systems
    • Breast Cancer Tumor Marker Tests
    • Blood Chemistries and Blood Cell Count
    • Biopsies
    • Other Diagnostic Imaging Tests
  • Infectious Disease Testing
    • Urinary Tract Infection Testing
    • MRSA Testing
    • Hepatitis Testing
    • Tuberculosis Testing
    • Other Infectious Disease Testing
  • Cervical Cancer Testing
    • Pap Smear
    • HPV Testing
  • Osteoporosis Testing
    • Bone Densitometry
    • In Vitro Blood Tests
  • Sexually Transmitted Disease Testing
    • Chlamydia Trachomatis And Neisseria Gonorrhoeae (Ct/Ng) Testing
    • HIV Testing
    • Other Sexually Transmitted Diseases
  • Prenatal Genetic Screening and Carrier Testing
    • Cystic Fibrosis
    • Down Syndrome and Edward Syndrome
    • TORCH Infections
    • Other Diseases
  • Ultrasound
    • OB/GYN Imaging
    • Breast Imaging
  • Pregnancy and Fertility Testing
    • Pregnancy Testing and Ovulation Prediction Kits
    • Lab-based Testing
    • Fertility Monitors
  • Ovarian Cancer Testing
    • Ovarian Cancer Tumor Marker Tests
    • Diagnostic Imaging Tests
    • Other Tests

Global women health diagnostics market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • RoW
    • Latin America
    • Middle East & Africa

Available customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

  • Product Analysis
    • Product matrix which gives a detailed comparison of the product portfolios of each company
  • Geographic Analysis
    • Further breakdown of the Rest of Asia-Pacific women’s health diagnostics market into South Korea, Australia, New Zealand, and others
    • Further breakdown of the Latin American women’s health diagnostics market into Mexico, Brazil, Argentina, and Rest of Latin America.
  • Company Information
    • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 22)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 26)
    2.1 Research Data
           2.1.1 Secondary Data
                     2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                     2.1.2.1 Key Data From Primary Sources
                     2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 34)

4 Premium Insights (Page No. - 37)
    4.1 Women’s Health Diagnostics: Market Overview
    4.2 Asia-Pacific: Pregnancy and Fertility Testing Market, By Product Type (2015)
    4.3 Geographic Snapshot of the Women’s Health Diagnostics Market
    4.4 Geograpgic Mix: Women’s Health Diagnostics Market
    4.5 Women’s Health Diagnostics Market: Developed vs Developing Markets

5 Market Overview (Page No. - 42)
    5.1 Introduction
    5.2 Key Market Dynamics
           5.2.1 Key Market Drivers
                     5.2.1.1 High Prevalence of Infectious Diseases in Women
                     5.2.1.2 Rising Incidence of Chronic and Lifestyle-Related Disorders in Women
                     5.2.1.3 Increasing Awareness About Fertility Testing in Women and IniTIAtives Taken By Government and Health Organizations
                     5.2.1.4 Increased Adoption of Point-Of-Care and Rapid Diagnostic Tests
                     5.2.1.5 Growth in the Number of Private Diagnostic and Imaging Centers
                     5.2.1.6 Public-Private Partnerships to Enhance the Infrastructure of Diagnostic Imaging Centers
           5.2.2 Key Market Restraints
                     5.2.2.1 High Cost of Diagnostic Imaging Systems and Procedures
                     5.2.2.2 Shortage of Skilled Laboratory Technicians
           5.2.3 Key Market Opportunities
                     5.2.3.1 Improving Healthcare Infrastructure in Emerging Markets
                     5.2.3.2 Growing Number of Regulatory Approvals for Immunoassay Diagnostic Techniques
           5.2.4 Key Market Challenges
                     5.2.4.1 Stringent Regulatory Guidelines
                     5.2.4.2 Increasing Adoption of Refurbished Diagnostic Imaging Systems

6 Industry Insights (Page No. - 53)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Growing Focus on Microfluidics- and Nanotechnology-Based POC Devices for Diagnostics
                     6.2.1.1 Microfluidics-Based Lab-On-A-Chip (LoC) Devices for Laboratory Testing
                     6.2.1.2 Evolution of Paper-Based Microfluidic Poc Diagnostic Devices
           6.2.2 Rising Focus of Market Players on Pregnancy and Fertility Issues in Emerging Regions
    6.3 Clinical Trials Assessment for Breast Cancer Diagnostics

7 Women’s Health Diagnostics Market, By Application (Page No. - 58)
    7.1 Introduction
    7.2 Osteoporosis Testing
           7.2.1 Bone Densitometry
           7.2.2 in Vitro Blood Tests
    7.3 Breast Cancer Testing
           7.3.1 Mammography
           7.3.2 Breast Cancer Tumor Marker Tests
           7.3.3 Blood Chemistries and Blood Cell Count Tests
           7.3.4 Biopsies
           7.3.5 Other Diagnostic Imaging Tests
    7.4 Ovarian Cancer Testing
           7.4.1 Ovarian Cancer Tumor Marker Tests
           7.4.2 Diagnostic Imaging Tests
           7.4.3 Other Tests
    7.5 Cervical Cancer Testing
           7.5.1 PAP Smear
           7.5.2 HPV Testing
    7.6 Pregnancy and Fertility Testing
           7.6.1 Lab-Based Testing
           7.6.2 Pregnancy Testing and Ovulation Prediction Kits
           7.6.3 Fertility Monitors
    7.7 Prenatal Genetic Screening and Carrier Testing
           7.7.1 Cystic Fibrosis
           7.7.2 Down Syndrome and Edwards Syndrome
           7.7.3 Torch Infections
           7.7.4 Other Diseases
    7.8 Infectious Disease Testing
           7.8.1 MRSA Testing
           7.8.2 Urinary Tract Infection Testing (Vaginal Ph & Vaginitis)
           7.8.3 HEPAtitis Testing
           7.8.4 Tuberculosis Testing
           7.8.5 Other Infectious Diseases
    7.9 Sexually Transmitted Disease Testing
           7.9.1 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) Testing
           7.9.2 HIV Testing
           7.9.3 Other Sexually Transmitted Diseases
    7.10 Ultrasound Tests
           7.10.1 Breast Imaging
           7.10.2 OB/GYN Imaging

8 Women’s Health Diagnostics Market, By End User (Page No. - 108)
    8.1 Introduction
    8.2 Hospitals and Clinics
    8.3 Diagnostic and Imaging Centers
    8.4 Home Care

9 Women’s Health Diagnostics Market, By Region (Page No. - 115)
    9.1 Introduction
    9.2 North America
           9.2.1 U.S.
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 U.K.
           9.3.3 France
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 Rest of Europe
    9.4 Asia-Pacific
           9.4.1 Japan
           9.4.2 China
           9.4.3 India
           9.4.4 Rest of Asia-Pacific
    9.5 RoW
           9.5.1 Latin America
           9.5.2 Middle East & Africa

10 Competitive Landscape (Page No. - 232)
     10.1 Overview
     10.2 Strategic Benchmarking
     10.3 Competitive Situations and Trends
               10.3.1 Product Launches
               10.3.2 Agreements, Partnerships, and Collaborations
               10.3.3 Acquisitions
               10.3.4 Regulatory Approvals

11 Company Profiles (Page No. - 241)
(Overview, Products and Services, Financials, Strategy & Development)*
     11.1 Siemens AG
     11.2 Quest Diagnostics Inc.
     11.3 Hologic, Inc.
     11.4 F. Hoffmann-La Roche AG
     11.5 Perkinelmer Inc.
     11.6 Alere Inc.
     11.7 GE Healthcare
     11.8 Becton, Dickinson and Company
     11.9 Abbott Laboratories
     11.10 Biomérieux SA
     11.11 Koninklijke Philips N.V.

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 279)
     12.1 Insights of Industry Experts
     12.2 Discussion Guide
     12.3 Other Developments
     12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     12.5 Introducing RT: Real-Time Market Intelligence
     12.6 Available Customizations
     12.7 Related Reports


List of Tables (265 Tables)

Table 1 Rising Incidence of Chronic and Lifestyle-Related Disorders in Women to Drive Market Growth
Table 2 High Cost of Diagnostic Imaging Systems and Procedures Affecting the Rate of Adoption in Emerging Markets
Table 3 Improving Healthcare Infrastructure in Emerging Markets to Play A Major Role in the Growth of the Women’s Health Diagnostics Market
Table 4 Stringent Regulatory Guidelines Pose A Challenge for Diagnostic Device Manufacturers
Table 5 Women’s Health Diagnostics Market: Product Portfolio Analysis
Table 6 Global Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 7 Global Osteoporosis Testing Market Size, By Type, 2014-2021 (USD Million)
Table 8 Global Osteoporosis Testing Market Size, By Country, 2014-2021 (USD Million)
Table 9 Global Bone Densitometry Market Size, By Country, 2014-2021 (USD Million)
Table 10 Global in Vitro Blood Tests Market Size, By Country, 2014-2021 (USD Million)
Table 11 Global Breast Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 12 Global Breast Cancer Testing Market Size, By Country, 2014-2021 (USD Million)
Table 13 Global Mammography Systems Market Size, By Country, 2014-2021 (USD Million)
Table 14 Global Breast Cancer Tumor Marker Tests Market Size, By Country, 2014-2021 (USD Million)
Table 15 Global Blood Chemistries and Blood Cell Count Tests Market Size, By Country, 2014-2021 (USD Million)
Table 16 Global Biopsies Market Size, By Country, 2014-2021 (USD Million)
Table 17 Global Other Diagnostic Imaging Tests Market Size, By Country, 2014-2021 (USD Million)
Table 18 Global Ovarian Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 19 Global Ovarian Cancer Testing Market Size, By Country, 2014-2021 (USD Million)
Table 20 Global Ovarian Cancer Tumor Marker Tests Market Size, By Country, 2014-2021 (USD Million)
Table 21 Global Diagnostic Imaging Tests Market Size, By Country, 2014-2021 (USD Million)
Table 22 Global Other Ovarian Cancer Tests Market Size, By Country/Region, 2014-2021 (USD Million)
Table 23 Global Cervical Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 24 Global Cervical Cancer Testing Market Size, By Country, 2014-2021 (USD Million)
Table 25 Global PAP Smear Market Size, By Country, 2014-2021 (USD Million)
Table 26 Global HPV Testing Market Size, By Country, 2014-2021 (USD Million)
Table 27 Global Pregnancy and Fertility Testing Market Size, By Type, 2014-2021 (USD Million)
Table 28 Global Pregnancy and Fertility Testing Market Size, By Country, 2014-2021 (USD Million)
Table 29 Global Lab-Based Testing Market Size, By Country, 2014-2021 (USD Million)
Table 30 Global Pregnancy and Ovulation Prediction Kits Testing Market Size, By Country, 2014-2021 (USD Million)
Table 31 Global Fertility Monitors Market Size, By Country, 2014-2021 (USD Million)
Table 32 Global Prenatal Genetic Screening and Carrier Testing Market Size, By Type, 2014-2021 (USD Million)
Table 33 Global Prenatal Genetic Screening and Carrier Testing Market Size, By Country, 2014-2021 (USD Million)
Table 34 Global Cystic Fibrosis Market Size, By Country, 2014-2021 (USD Million)
Table 35 Global Down Syndrome and Edwards Syndrome Market Size, By Country, 2014-2021 (USD Million)
Table 36 Global Torch Infections Market Size, By Country, 2014-2021 (USD Million)
Table 37 Global Other Diseases Market Size, By Country, 2014-2021 (USD Million)
Table 38 Global Infectious Disease Testing Market Size, By Type, 2014-2021 (USD Million)
Table 39 Global Infectious Disease Testing Market Size, By Country, 2014-2021 (USD Million)
Table 40 Global MRSA Testing Market Size, By Country, 2014-2021 (USD Million)
Table 41 Global Urinary Tract Infection Testing Market Size, By Country, 2014-2021 (USD Million)
Table 42 Global HEPAtitis Testing Market Size, By Country, 2014-2021 (USD Million)
Table 43 Global Tuberculosis Testing Market Size, By Country, 2014-2021 (USD Million)
Table 44 Global Other Infectious Disease Testing Market Size, By Country, 2014-2021 (USD Million)
Table 45 Global Sexually Transmitted Disease Testing Market Size, By Type, 2014-2021 (USD Million)
Table 46 Global Sexually Transmitted Disease Testing Market Size, By Country, 2014-2021 (USD Million)
Table 47 Global CT/NG Testing Market Size, By Country, 2014-2021 (USD Million)
Table 48 Global HIV Testing Market Size, By Country, 2014-2021 (USD Million)
Table 49 Global Other Sexually Transmitted Diseases Market Size, By Country, 2014-2021 (USD Million)
Table 50 Global Ultrasound Tests Market Size, By Type, 2014-2021 (USD Million)
Table 51 Global Ultrasound Tests Market Size, By Country, 2014-2021 (USD Million)
Table 52 Global Breast Imaging Market Size, By Country, 2014-2021 (USD Million)
Table 53 Global OB/GYN Market Size, By Country, 2014-2021 (USD Million)
Table 54 Global Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 55 Global Women’s Health Diagnostics Market Size for Hospitals and Clinics, By Country, 2014–2021 (USD Million)
Table 56 Global Women’s Health Diagnostics Market Size for Diagnostic and Imaging Centers, By Country, 2014–2021 (USD Million)
Table 57 Global Women’s Health Diagnostics Market Size for Home Care, By Country, 2014–2021 (USD Million)
Table 58 Women’s Health Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 59 North America: Women’s Health Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 60 North America: Women’s Health Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 61 North America: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 62 North America: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 63 North America: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 64 North America: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 65 North America: Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 66 North America: Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 67 North America: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 68 North America: Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 69 North America: Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 70 North America: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 71 U.S.: Women’s Health Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 72 U.S.: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 73 U.S.: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 74 U.S.: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 75 U.S.: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 76 U.S.: Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 77 U.S.: Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 78 U.S.: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 79 U.S.: Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 80 U.S.: Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 81 U.S.: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 82 Canada: Women’s Health Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 83 Canada: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 84 Canada: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 85 Canada: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 86 Canada: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 87 Canada: Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 88 Canada: Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 89 Canada: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 90 Canada: Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 91 Canada: Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 92 Canada: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 93 Europe: Women’s Health Diagnostics Market Size, By Country, 2014-2021(USD Million)
Table 94 Europe: Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 95 Europe: Breast Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 96 Europe: Osteoporosis Testing Market Size, By Type, 2014-2021 (USD Million)
Table 97 Europe: Infectious Disease Testing Market Size, By Disease, 2014-2021 (USD Million)
Table 98 Europe: Pregnancy and Fertility Testing Market Size, By Type, 2014-2021 (USD Million)
Table 99 Europe: Ultrasound Market Size, By Application, 2014-2021 (USD Million)
Table 100 Europe: Sexually Transmitted Diseases Market Size, By Disease Type, 2014-2021 (USD Million)
Table 101 Europe: Prenatal Genetic and Carrier Testing Market Size, By Disease Type,2014-2021 (USD Million)
Table 102 Europe: Cervical Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 103 Europe: Ovarian Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 104 Europe: Women’s Health Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 105 Germany: Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 106 Germany: Breast Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 107 Germany: Osteoporosis Testing Market Size, By Type, 2014-2021 (USD Million)
Table 108 Germany: Infectious Disease Testing Market Size, By Disease, 2014-2021 (USD Million)
Table 109 Germany: Pregnancy and Fertility Testing Market Size, By Type, 2014-2021 (USD Million)
Table 110 Germany: Ultrasound Market Size, By Application, 2014-2021 (USD Million)
Table 111 Germany: Sexually Transmitted Diseases Market Size, By Disease Type, 2014-2021 (USD Million)
Table 112 Germany: Prenatal Genetic and Carrier Testing Market Size, By Disease Type,2014-2021 (USD Million)
Table 113 Germany: Cervical Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 114 Germany: Ovarian Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 115 Germany: Women’s Health Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 116 U.K.: Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 117 U.K: Breast Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 118 U.K: Osteoporosis Testing Market Size, By Type, 2014-2021 (USD Million)
Table 119 U.K: Infectious Disease Testing Market Size, By Disease, 2014-2021 (USD Million)
Table 120 U.K: Pregnancy and Fertility Testing Market Size, By Type, 2014-2021 (USD Million)
Table 121 U.K: Ultrasound Market Size, By Application, 2014-2021 (USD Million)
Table 122 U.K: Sexually Transmitted Diseases Market Size, By Disease Type, 2014-2021 (USD Million)
Table 123 U.K: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014-2021 (USD Million)
Table 124 U.K: Cervical Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 125 U.K: Ovarian Cancer Testing Market Size, By Type,2014-2021 (USD Million)
Table 126 U.K: Women’s Health Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 127 France: Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 128 France: Breast Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 129 France: Osteoporosis Testing Market Size, By Type, 2014-2021 (USD Million)
Table 130 France : Infectious Disease Testing Market Size, By Disease, 2014-2021 (USD Million)
Table 131 France: Pregnancy and Fertility Testing Market Size, By Type, 2014-2021 (USD Million)
Table 132 France: Ultrasound Market Size, By Application, 2014-2021 (USD Million)
Table 133 France: Sexually Transmitted Diseases Market Size, By Disease Type, 2014-2021 (USD Million)
Table 134 France: Prenatal Genetic and Carrier Testing Market Size, By Disease Type,2014-2021 (USD Million)
Table 135 France: Cervical Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 136 France: Ovarian Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 137 France: Women’s Health Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 138 Italy : Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 139 Italy: Breast Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 140 Italy: Osteoporosis Testing Market Size, By Type, 2014-2021 (USD Million)
Table 141 Italy : Infectious Disease Testing Market Size, By Disease, 2014-2021 (USD Million)
Table 142 Italy: Pregnancy and Fertility Testing Market Size, By Type, 2014-2021 (USD Million)
Table 143 Italy: Ultrasound Market Size, By Application, 2014-2021 (USD Million)
Table 144 Italy: Sexually Transmitted Diseases Market Size, By Disease Type, 2014-2021 (USD Million)
Table 145 Italy: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014-2021 (USD Million)
Table 146 Italy: Cervical Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 147 Italy: Ovarian Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 148 Italy: Women’s Health Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 149 Spain: Women’s Health Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 150 Spain: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 151 Spain: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 152 Spain: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 153 Spain : Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 154 Spain : Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 155 Spain : Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 156 Spain : Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 157 Spain : Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 158 Spain : Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 159 Spain : Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 160 RoE: Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 161 RoE: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 162 RoE: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 163 RoE: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 164 RoE: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 165 RoE: Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 166 RoE: Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 167 RoE: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 168 RoE: Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 169 RoE: Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 170 RoE: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 171 APAC: Women’s Health Diagnostics Market Size, By Country, 2014–2021(USD Million)
Table 172 APAC: Women’s Health Diagnostics Market Size, By Application, 2014–2021(USD Million)
Table 173 APAC: Breast Cancer Testing, By Type, (USD Million)
Table 174 APAC: Osteoporosis Testing, By Type, 2014–2021 (USD Million)
Table 175 APAC: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 176 APAC: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 177 APAC: Ultrasound Market Size, By Application, 2014–2021 (USD Million)
Table 178 APAC: Sexually Transmitted Diseases Market Size, By Disease Type, 2014–2021 (USD Million)
Table 179 APAC: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 180 APAC: Cervical Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 181 APAC: Ovarian Cancer Market Size, By Testing, 2014–2021 (USD Million)
Table 182 APAC: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 183 Japan: Women’s Health Diagnostics Market Size, By Application, 2014–2021(USD Million)
Table 184 Japan: Breast Cancer Testing, By Type, 2014–2021 (USD Million)
Table 185 Japan: Osteoporosis Testing, By Type, 2014–2021 (USD Million)
Table 186 Japan: Infectious Disease Testing Market Size, By Disease, 2014–2021, (USD Million)
Table 187 Japan: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021, (USD Million)
Table 188 Japan: Ultrasound Market Size, By Application, 2014–2021 (USD Million)
Table 189 Japan: Sexually Transmitted Diseases Market Size, By Disease Type, 2014–2021 (USD Million)
Table 190 Japan: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 191 Japan: Cervical Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 192 Japan: Ovarian Cancer Market Size, By Testing, 2014–2021 (USD Million)
Table 193 Japan: Women’s Health Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 194 China: Women’s Health Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 195 China: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 196 China: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 197 China: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 198 China: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 199 China: Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 200 China: Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 201 China: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 202 China: Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 203 China: Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 204 China: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 205 India: Women’s Health Diagnostics Market Size, By Application, 2014–2021(USD Million)
Table 206 India: Breast Cancer Testing, By Type, 2014–2021 (USD Million)
Table 207 India: Osteoporosis Testing, By Type, 2014–2021 (USD Million)
Table 208 India: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 209 India: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 210 India: Ultrasound Market Size, By Application, 2014–2021 (USD Million)
Table 211 India: Sexually Transmitted Diseases Market Size, By Disease Type, 2014–2021 (USD Million)
Table 212 India: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 213 India: Cervical Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 214 India: Ovarian Cancer Market Size, By Testing, 2014–2021 (USD Million)
Table 215 India: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 216 RoAPAC: Women’s Health Diagnostics Market Size, By Application, 2014–2021(USD Million)
Table 217 RoAPAC: Breast Cancer Testing, By Type, (USD Million)
Table 218 RoAPAC: Osteoporosis Testing, By Type, 2014–2021 (USD Million)
Table 219 RoAPAC: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 220 RoAPAC: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021, (USD Million)
Table 221 RoAPAC: Ultrasound Market Size, By Application, 2014–2021 (USD Million)
Table 222 RoAPAC: Sexually Transmitted Diseases Market Size, By Disease Type, 2014–2021 (USD Million)
Table 223 RoAPAC: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 224 RoAPAC: Cervical Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 225 RoAPAC: Ovarian Cancer Market Size, By Testing, 2014–2021, (USD Million)
Table 226 RoAPAC: Women’s Health Diagnostics Market Size, By End User (USD Million)
Table 227 RoW: Women’s Health Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 228 RoW: Women’s Health Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 229 RoW: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 230 RoW: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 231 RoW: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 232 RoW: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 233 RoW: Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 234 RoW: Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 235 RoW: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 236 RoW: Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 237 RoW: Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 238 RoW: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 239 Latin America: Women’s Health Diagnostics Market Size, By Application, 2014–2021 (USD Million)
Table 240 Latin America: Breast Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 241 Latin America: Osteoporosis Testing Market Size, By Type, 2014–2021 (USD Million)
Table 242 Latin America: Infectious Disease Testing Market Size, By Disease, 2014–2021 (USD Million)
Table 243 Latin America: Pregnancy and Fertility Testing Market Size, By Type, 2014–2021 (USD Million)
Table 244 Latin America: Ultrasound Market Size, By Application, 2014–2021, (USD Million)
Table 245 Latin America: Sexually Transmitted Disease Testing Market Size, By Disease Type, 2014–2021 (USD Million)
Table 246 Latin America: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014–2021, (USD Million)
Table 247 Latin America: Cervical Cancer Testing Market Size, By Type, 2014–2021, (USD Million)
Table 248 Latin America: Ovarian Cancer Testing Market Size, By Type, 2014–2021 (USD Million)
Table 249 Latin America: Women’s Health Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 250 Middle East & Africa: Women’s Health Diagnostics Market Size, By Application, 2014-2021 (USD Million)
Table 251 Middle East & Africa: Breast Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 252 Middle East & Africa: Osteoporosis Testing Market Size, By Type, 2014-2021 (USD Million)
Table 253 Middle East & Africa: Infectious Disease Testing Market Size, By Disease, 2014-2021 (USD Million)
Table 254 Middle East & Africa: Pregnancy and Fertility Testing Market Size, By Type, 2014-2021 (USD Million)
Table 255 Middle East & Africa: Ultrasound Market Size, By Application, 2014-2021 (USD Million)
Table 256 Middle East & Africa: Sexually Transmitted Diseases Market Size, By Disease Type, 2014-2021 (USD Million)
Table 257 Middle East & Africa: Prenatal Genetic and Carrier Testing Market Size, By Disease Type, 2014-2021 (USD Million)
Table 258 Middle East & Africa: Cervical Cancer Testing Market Size, By Type, 2014-2021 (USD Million)
Table 259 Middle East & Africa: Ovarian Cancer Market Size, By Type, 2014-2021 (USD Million)
Table 260 Middle East & Africa: Women’s Health Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 261 Growth Strategy Matrix (2013–2016)
Table 262 Product Launches, 2013–2016
Table 263 Agreements, Partnerships, and Collaborations, 2013–2016
Table 264 Acquisitions, 2013–2016
Table 265 Regulatory Approvals, 2013–2016
 
 
List of Figures (37 Figures)
 
Figure 1 Global Women’s Health Diagnostics Market
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Women’s Health Diagnostics Market, By Application, 2016 vs 2021
Figure 7 Women’s Health Diagnostics Market, By End User, 2016 vs 2021
Figure 8 Geographic Snapshot: Women’s Health Diagnostics Market
Figure 9 High Prevalence of Infectious Diseases in Women and Rising Incidence of Chronic and Lifestyle-Related Disorders in Women are Driving Growth in the Women’s Health Diagnostics Market
Figure 10 Pregnancy Testing and Ovulation Prediction Kits Segment Accounted for the Largest Share of the Asia-Pacific Pregnancy and Fertility Testing Market in 2015
Figure 11 The U.S. Commanded the Largest Share of the Women’s Health Diagnostics Market in 2015
Figure 12 APAC to Witness the Highest Growth Rate During the Forecast Period
Figure 13 Developing Markets to Register Higher Growth Rates During the Forecast Period
Figure 14 Women’s Health Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 15 Clinical Studies for Breast Cancer Diagnostic Devices (2013-2016)
Figure 16 Breast Cancer Segment to Dominate the Market in 2016
Figure 17 Mammography Segment to Dominate the Market During the Forecast Period
Figure 18 Urinary Tract Infections Testing Segment to Dominate  the Market in 2016
Figure 19 The Hospitals & Clinics End-User Segment Will Continue to Dominate the Global Women’s Health Diagnostics Market in 2021
Figure 20 North America: Women’s Health Diagnostics Market Snapshot
Figure 21 Europe: Women’s Health Diagnostics Market Snapshot
Figure 22 Asia-Pacific: Women’s Health Diagnostics Market Snapshot
Figure 23 Product Launch—Key Growth Strategy Adopted By Market Players From 2013 to September 2016
Figure 24 List of New Product Launches By Key Players in the Market From 2014 - 2016
Figure 25 Key Acquisitions: Women’s Health Diagnostics Market (2014–2016)
Figure 26 Battle for Market Share: Product Launch Accounted for the Largest Share During 2013 to 2016
Figure 27 Company Snapshot: Siemens AG
Figure 28 Company Snapshot: Quest Diagnostics Inc.
Figure 29 Company Snapshot: Hologic, Inc.
Figure 30 Company Snapshot: F. Hoffmann-La Roche AG
Figure 31 Company Snapshot: Perkinelmer Inc.
Figure 32 Company Snapshot: Alere Inc.
Figure 33 Company Snapshot: GE Healthcare
Figure 34 Company Snapshot: Becton, Dickinson and Company
Figure 35 Company Snapshot: Abbott Laboratories
Figure 36 Company Snapshot: Biomérieux SA
Figure 37 Company Snapshot: Koninklijke Philips N.V.

The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period. This market is mainly driven by the increased adoption of point-of-care & rapid diagnostic tests, growth in the number of private diagnostic centers, high prevalence of infectious diseases in women, rising incidence of chronic & lifestyle-related disorders in women and increasing awareness about fertility testing in women & initiatives taken by government and health organizations. Moreover, improving healthcare infrastructure in emerging markets and growing number of regulatory approvals for immunoassay techniques further provide significant growth opportunities for market players in the women health diagnostics market. However, high cost of diagnostic imaging systems & procedures and shortage of skilled laboratory technicians are the major factors hampering the growth of this market.

In this report, the global women’s health diagnostics market is segmented on the basis of applications, and end users. On the basis of application, the market is segmented into various segments, namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound. On the basis of end user, the global women health diagnostics is segmented into three segments, namely, hospital and clinics, home healthcare, and diagnostic & imaging centers.

In 2015, the breast cancer testing segment accounted for the largest share of the market. However, the prenatal genetic screening and carrier testing segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to factors such as the growing number of doctors offering genetic screening tests to pregnant women and growing awareness about these tests.

Geographically, the women’s health diagnostics market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2015, North America commanded the largest share, followed by Europe, Asia-Pacific, and the RoW. Asia-Pacific represented the fastest-growing region for the women health diagnostics market, primarily due to improving healthcare infrastructure, growing per capita income, growing awareness among women regarding various health disorders, and rising focus of key market players on this region.

Women's Health Diagnostics Market

The global women’s health diagnostics market is a mature market and characterized by the presence of number of players. This industry is witnessing an increasing number of acquisitions, product launches and alliances such as partnerships, agreements, and collaborations between players offering better women health diagnostics solutions. Major players in the global women’s health diagnostics market are Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V. (Netherlands).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo